Original news and analysis on international IP policy
Two not-for-profit drug developers, TB Alliance and the Drugs for Neglected Diseases initiative (DNDi), have created a product development partnership (PDP) in the form of a royalty-free licence agreement intended to drive development of new drugs for several neglected diseases.…
The last chance to complete discussions and reach an agreement on a draft protocol text on access and benefit-sharing is given to member parties of the UN Convention on Biodiversity (CBD) next week. The protocol is intended to provide a new international tool for governments against piracy of genetic resources.
Yesterday, the European Court of Justice ruled in a case pitching Monsanto against European importers of Argentinean soy meal, denying the US seed giant intellectual property rights over the exports of soy meal from Argentina to the European Union.
“Exactly a year ago, a very bad decision was taken” by the World Health Organization that now seems “unscientific and irrational,” said Council of Europe parliamentarian Paul Flynn in a late June presentation of a new report on the WHO's actions during the 2009 influenza pandemic.
But opinions heard at an ongoing review of the WHO’s pandemic response were mixed, with some praising the organisation’s work to protect public health and others critiquing what they say is suspicious secrecy.
In five short years, Intellectual Property Watch has made its mark as the leading independent reporting service on international IP policymaking, respected for its timely and informed content by readers from international organizations, industry, NGOs, civil society, research centres, government, as well as academia. We have provoked debate, exposed controversies, and helped thousands to access a policy conversation long seen as highly technical and closed.
With dramatic shifts occurring in the field of IP and innovation policy and law, our reporting has never been more relevant. But to keep on providing the independent, open-access service that so many of you have come to rely upon, we need your help in the next 3 (THREE!) weeks. By late July, we need to make a decision about IP-Watch's future.
LUCERNE, SWITZERLAND - There was progress during the ninth round of negotiations for the Anti-Counterfeiting Trade Agreement (ACTA) this week in Lucerne, negotiators said over the last day, and in their final press communiqué they made promises that “ACTA will not interfere with a signatory's ability to respect fundamental rights and liberties,” it would be consistent with World Trade Organization agreements and certainly “not hinder the cross-border transit of legitimate generic medicine.”
On 1 July, the same day the presidency of the European Patent Office (EPO) transferred to Benoît Battistelli and the EU presidency shifted from Spain to Belgium, the European Commission presented the EPO with a proposal on translation arrangements for…
Filing of financial patents seems to be on a parallel upward trend with litigation in the United States, with large companies being prime targets, and individual or small entities owning the patents, according to a well-known US economist. This could be the consequence of low quality patents being granted, he said.
An agreement on international intellectual property rights enforcement now under negotiation in Lucerne, Switzerland runs the risk of ushering in a new and undemocratic precedent for international policymaking that could have long-term damaging effects on critical public policy issues, non-negotiating government representatives and civil society advocates said this week.
The plurilateral Anti-Counterfeiting Trade Agreement (ACTA) and other such regional negotiations are a “bad development” for multilateral agencies, the World Intellectual Property Organization director general has told Intellectual Property Watch.
The United States Supreme Court yesterday handed down an important patent law ruling. By a narrow 5-4 vote, the court held in Bilski v. Kappos that business methods are patentable under US law. But the court provided only limited guidance on how to determine which business methods (and other types of inventions) are indeed patentable.
La petite ville guindée de Lucerne, en Suisse, accueille cette semaine le neuvième round de négociations visant à la signature de l’Accord Commercial Anti-Contrefaçon (plus connu sous sa dénomination anglaise, ACTA : Anti-Counterfeiting Trade Agreement). Pendant que les onze parties prenantes aux négociations devaient se retrouver au Palace Hotel, le Parti Pirate suisse et ses homologues allemands et autrichiens devaient organiser un rassemblement en gare de Lucerne.